project id: TCGA-CESC; case submitter id: TCGA-EK-A2RL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.4; age at index: 32; days to birth: -12047; days to death: 1453; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1977; age at diagnosis: 12047; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 721.0; figo stage: Stage IB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8384/3; primary diagnosis: Adenocarcinoma, endocervical type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 723; initial weight: 140.0; oct embedded: false; preservation method: Unknown; sample id: dd3e80d9-0321-40ad-b963-25e2c94c6092; sample submitter id: TCGA-EK-A2RL-01A; portion id: 483698bc-a9f3-4172-a95b-b9ba77779e94; portion submitter id: TCGA-EK-A2RL-01A-11; slide id: f2cd492a-f4d7-4939-bfbc-25ca2ed7868b; slide submitter id: TCGA-EK-A2RL-01A-01-TS1; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 73.0; percent tumor nuclei: 70.0; section location: TOP;